Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

Completed · Phase 2 · Has a placebo group

Conditions studied: Pain, Acute

In brief

Phase 2 study designed to evaluated analgesic efficacy and safety of S-Ibuprofen Topical Gel 5%

Key facts

Study ID

NCT03852459

Run by

Aponia Laboratories, Inc.

People needed

251

Starts

2018-01-12

Expected to finish

2019-04-11

Last updated by the study team

2022-01-25

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• history of pain/soreness after exercise
• BMI between 18-30
• negative drug, alcohol, pregnancy screens
• other protocol-defined inclusion criteria may apply

You may not qualify if…

• upper extremity workout in last 3 months
• job or hobby requiring heavy lifting
• history of muscle disorders
• allergy or intolerance to NSAID or study drug
• history of recent pain medication use
• other protocol-defined exclusion criteria may apply

Where it is running

• JBR Clinical Research — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.